RecruitingPhase IIEN originalProstate cancerMetastatic / advanced

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous surgery or biopsy procedure and tested for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) abnormalities or mutations in their cancer. Valemetostat tosylate is in a class of medications called EZH1/EZH2 inhibitors. It blocks proteins called EZH1 and EZH2, which may help slow or stop the spread of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Cabazitaxel injection is in a class of medications called microtubule inhibitors. It works by slowing or stopping the growth of tumor cells. Abiraterone acetate blocks tissues from making androgens (male hormones), such as testosterone. This may cause the death of tumor cells that need androgens to grow. It is a type of anti-androgen. Enzalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of tumor cells. Lutetium Lu 177 vipivotide tetraxetan is in a class of medications called radiopharmaceuticals. It works by targeting and delivering radiation directly to tumor cells which damages and kills these cells. Assigning patients to targeted treatment based on genetic testing may help shrink or slow the cancer from growing

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzona diagnosis raka prostaty (biopsja lub badanie tkanki)
  • Obecność przerzutów raka
  • Próbka tkanki raka dostępna z ostatnich 12 miesięcy
  • Wynik testu genetycznego (badanie DNA/RNA) wykonany w certyfikowanym laboratorium
  • Wiek co najmniej 18 lat
  • Rak oporny na leczenie hormonalne (niski poziom testosteronu w krwi)

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 5, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (108)

University of Alabama at Birmingham Cancer Center

Birmingham, United States

Banner University Medical Center - Tucson

Tucson, United States

University of Arizona Cancer Center-North Campus

Tucson, United States

Enloe Medical Center

Chico, United States

UC San Diego Health System - Encinitas

Encinitas, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

Irvine, United States

UC San Diego Moores Cancer Center

La Jolla, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center

Orange, United States

University of California Davis Comprehensive Cancer Center

Sacramento, United States

UC San Diego Medical Center - Hillcrest

San Diego, United States

UCHealth Memorial Hospital Central

Colorado Springs, United States

Memorial Hospital North

Colorado Springs, United States

Poudre Valley Hospital

Fort Collins, United States

Cancer Care and Hematology-Fort Collins

Fort Collins, United States

UCHealth Greeley Hospital

Greeley, United States

Medical Center of the Rockies

Loveland, United States

Stamford Hospital/Bennett Cancer Center

Stamford, United States

Beebe South Coastal Health Campus

Millville, United States

Helen F Graham Cancer Center

Newark, United States

Medical Oncology Hematology Consultants PA

Newark, United States

Beebe Health Campus

Rehoboth Beach, United States

Jupiter Medical Center

Jupiter, United States

Tripler Army Medical Center

Honolulu, United States

Kootenai Health - Coeur d'Alene

Coeur d'Alene, United States

Illinois CancerCare-Bloomington

Bloomington, United States

Illinois CancerCare-Canton

Canton, United States

Carle at The Riverfront

Danville, United States

Carle Physician Group-Effingham

Effingham, United States

Illinois CancerCare-Eureka

Eureka, United States

Carle Physician Group-Mattoon/Charleston

Mattoon, United States

Cancer Care Center of O'Fallon

O'Fallon, United States

Illinois CancerCare-Ottawa Clinic

Ottawa, United States

Illinois CancerCare-Pekin

Pekin, United States

Illinois CancerCare-Peoria

Peoria, United States

Illinois CancerCare-Peru

Peru, United States

Memorial Hospital East

Shiloh, United States

Carle Cancer Center

Urbana, United States

Illinois CancerCare - Washington

Washington, United States

McFarland Clinic - Ames

Ames, United States

University of Iowa Healthcare Cancer Services Quad Cities

Bettendorf, United States

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, United States

University of Kansas Cancer Center

Kansas City, United States

The University of Kansas Cancer Center - Olathe

Olathe, United States

University of Kansas Hospital-Indian Creek Campus

Overland Park, United States

University of Kansas Health System Saint Francis Campus

Topeka, United States

University of Kansas Hospital-Westwood Cancer Center

Westwood, United States

Saint Elizabeth Healthcare Edgewood

Edgewood, United States

Saint Elizabeth Healthcare Fort Thomas

Fort Thomas, United States

Dana-Farber Cancer Institute

Boston, United States

Dana-Farber Cancer Institute at Foxborough

Foxborough, United States

Dana Farber-Merrimack Valley

Methuen, United States

Dana-Farber/Brigham and Women's Cancer Center at Milford Regional

Milford, United States

Dana-Farber/Brigham and Women's Cancer Center at South Shore

South Weymouth, United States

Baystate Medical Center

Springfield, United States

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, United States

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, United States

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, United States

University of Michigan Health - Sparrow Lansing

Lansing, United States

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, United States

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, United States

Essentia Health Saint Joseph's Medical Center

Brainerd, United States

Essentia Health Cancer Center

Duluth, United States

Coborn Cancer Center at Saint Cloud Hospital

Saint Cloud, United States

Siteman Cancer Center at Saint Peters Hospital

City of Saint Peters, United States

MU Health - University Hospital/Ellis Fischel Cancer Center

Columbia, United States

Siteman Cancer Center at West County Hospital

Creve Coeur, United States

Washington University School of Medicine

St Louis, United States

Siteman Cancer Center-South County

St Louis, United States

Siteman Cancer Center at Christian Hospital

St Louis, United States

Billings Clinic Cancer Center

Billings, United States

Hackensack University Medical Center

Hackensack, United States

Roswell Park Cancer Institute

Buffalo, United States

Mount Sinai Hospital

New York, United States

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, United States

Essentia Health Cancer Center-South University Clinic

Fargo, United States

MetroHealth Medical Center

Cleveland, United States

Ohio State University Comprehensive Cancer Center

Columbus, United States

University of Oklahoma Health Sciences Center

Oklahoma City, United States

Providence Portland Medical Center

Portland, United States

Providence Saint Vincent Medical Center

Portland, United States

Oregon Health and Science University

Portland, United States

Guthrie Medical Group PC-Robert Packer Hospital

Sayre, United States

Gibbs Cancer Center-Gaffney

Gaffney, United States

Gibbs Cancer Center-Pelham

Greer, United States

Spartanburg Medical Center

Spartanburg, United States

SMC Center for Hematology Oncology Union

Union, United States

Vanderbilt University/Ingram Cancer Center

Nashville, United States

Parkland Memorial Hospital

Dallas, United States

UT Southwestern Simmons Cancer Center - RedBird

Dallas, United States

UT Southwestern/Simmons Cancer Center-Dallas

Dallas, United States

UT Southwestern/Simmons Cancer Center-Fort Worth

Fort Worth, United States

UT Southwestern Clinical Center at Richardson/Plano

Richardson, United States

Bon Secours Memorial Regional Medical Center

Mechanicsville, United States

Bon Secours Saint Francis Medical Center

Midlothian, United States

Bon Secours Richmond Community Hospital

Richmond, United States

Bon Secours Saint Mary's Hospital

Richmond, United States

Bon Secours Cancer Institute at Reynolds Crossing

Richmond, United States

VCU Massey Cancer Center at Stony Point

Richmond, United States

VCU Massey Comprehensive Cancer Center

Richmond, United States

Swedish Cancer Institute-Edmonds

Edmonds, United States

Swedish Medical Center-First Hill

Seattle, United States

West Virginia University Charleston Division

Charleston, United States

Edwards Comprehensive Cancer Center

Huntington, United States

Marshfield Medical Center-Marshfield

Marshfield, United States

Froedtert Menomonee Falls Hospital

Menomonee Falls, United States

Medical College of Wisconsin

Milwaukee, United States

Drexel Town Square Health Center

Oak Creek, United States

Froedtert West Bend Hospital/Kraemer Cancer Center

West Bend, United States

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/6/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.